Eschar: an important clue to diagnosis

Por Sundriyal, Deepak, Kumar, Naveen, Chandrasekharan, Arun, Sharma, Brijesh
Publicado em 2013

Mauskopf facies

Por Sundriyal, Deepak, Kumar, Naveen, Chandrasekharan, Arun, Gadpayle, Adesh Kumar
Publicado em 2013

Activation of phosphoinositide 3-kinase/Akt/mechanistic target of rapamycin pathway and response to everolimus in endocrine receptor-positive metastatic breast cancer – A retrospec...

Por Bajpai, Jyoti, Ramaswamy, Anant, Chandrasekharan, Arun, Mishra, Surya, Shet, Tanuja, Gupta, Sudeep, Badwe, R. A.
Publicado no South Asian J Cancer (2017)

Long-term survival outcomes of technically unresectable carcinoma maxilla postinduction chemotherapy

Por Dhumal, Sachin Babanrao, Patil, Vijay M., Joshi, Amit, Noronha, Vanita, Chandrasekharan, Arun, Pai, Prathamesh, Prabhash, Kumar
Publicado no South Asian J Cancer (2018)

Neoadjuvant chemotherapy in technically unresectable adenocarcinoma of parotid

Por Dhumal, Sachin, Chandrasekharan, Arun, Patil, Vijay, Noronha, Vanita, Joshi, Amit, Puranik, Ameya, Rangarajan, Venkatesh, Prabhash, Kumar
Publicado no South Asian J Cancer (2019)

Metronomic palliative chemotherapy in maxillary sinus tumor

Por Patil, Vijay M., Noronh, Vanita, Joshi, Amit, Karpe, Ashay, Talreja, Vikas, Chandrasekharan, Arun, Dhumal, Sachin, Prabhash, Kumar
Publicado no South Asian J Cancer (2016)

Weekly paclitaxel as metronomic palliative chemotherapy in small cell lung cancer

Por Noronha, Vanita, Sahu, Arvind, Patil, Vijay M., Joshi, Amit, Ramaswamy, Anant, Chandrasekharan, Arun, Kadam, Nandkumar, Prabhash, Kumar
Publicado no South Asian J Cancer (2016)

A cross-sectional audit of distress in patients undergoing adjuvant therapy or follow-up in central nervous system malignancies

Por Patil, Vijay M, Malhotra, Mridul, Tonse, Raees, Deodhar, Jayita, Chandrasekharan, Arun, Pande, Nikhil, Bhattacharjee, Atanu, Jalali, Rakesh
Publicado no Neurooncol Pract (2019)

Palliative chemotherapy in carcinoma nasopharynx

Por Patil, Vijay M., Joshi, Amit, Noronha, Vanita, Talreja, Vikas, Simha, Vijai, Dhumal, Sachin, Bandekar, Bhavesh, Chandrasekharan, Arun, Prabhash, Kumar
Publicado no South Asian J Cancer (2019)

Antiemetic prophylaxis with temozolomide: an audit from a tertiary care center

Por Patil, Vijay M, Chandrasekharan, Arun, Vallathol, Dilip Harindran, Malhotra, Mridul, Abhinav, Ram, Agarwal, Priti, Rajpurohit, Anu, Tonse, Raees, Bhattacharjee, Atanu, Jalali, Rakesh
Publicado no Neurooncol Pract (2019)

Outcomes in Treatment-Naïve Patients With Metastatic Extremity Osteosarcoma Treated With OGS-12, a Novel Non–High-Dose Methotrexate–Based, Dose-Dense Combination Chemotherapy, in a...

Por Bajpai, Jyoti, Chandrasekharan, Arun, Simha, Vijai, Talreja, Vikas, Karpe, Ashay, Pandey, Nikihil, Singh, Ashish, Rekhi, Bharat, Vora, Tushar, Ghosh, Jaya, Banavali, Shripad, Gupta, Sudeep
Publicado no J Glob Oncol (2018)

Shadow study: randomized comparison of clinic with video follow-up in glioma undergoing adjuvant temozolomide therapy

Por Patil, Vijay M, Pande, Nikhil, Chandrasekharan, Arun, M, Chandrakanth, Tonse, Raees, Krishnatry, Rahul, Goda, Jayant S, Dsouza, Hollis, Vallathol, Dilip Harindran, Chakraborty, Santam, Gupta, Tejpal, Jalali, Rakesh
Publicado no CNS Oncol (2018)

Quality of life and quality-adjusted time without toxicity in palliatively treated head-and-neck cancer patients

Por Patil, Vijay, Joshi, Amit, Noronha, Vanita, Bhattacharjee, Atanu, Dhumal, Sachin, Chandrakanth, M. V., Karpe, Ashay, Talreja, Vikas, Chandrasekharan, Arun, Turkar, Siddharth, Pande, Nikhil, Ramaswamy, Anant, Prabhash, Kumar
Publicado no South Asian J Cancer (2018)

Distress Management in Patients With Head and Neck Cancer Before Start of Palliative Chemotherapy: A Practical Approach

Por Patil, Vijay, Noronha, Vanita, Joshi, Amit, Deodhar, Jayita, Goswami, Savita, Chakraborty, Santam, Ramaswamy, Anant, Dhumal, Sachin, M.V., Chandrakanth, Karpe, Ashay, Pande, Nikhil, Talreja, Vikas, Chandrasekharan, Arun, Turkar, Siddharth, Prabhash, Kumar
Publicado no J Glob Oncol (2018)

Randomized phase 3 open label study of quality of life of patients on Pemetrexed versus Erlotinib as maintenance therapy for advanced non squamous non EGFR mutated non small cell l...

Por Patil, Vijay, Joshi, Amit, Noronha, Vanita, Agarwala, Vivek, Chougule, Anuradha, Kanan, Sadhana, Bhattacharjee, Atanu, Chandrasekharan, Arun, Pande, Nikhil, Simha, Vijai, Goud, Supriya, More, Sucheta, Kumar, Rajiv, Mahajan, Abhishek, Janu, Amit, Purandare, Nilendu, Prabhash, Kumar
Publicado no Oncotarget (2019)

Impact of exon 19 versus exon 21 EGFR-activating mutation on outcomes with upfront pemetrexed–carboplatin chemotherapy

Por Noronha, Vanita, Patil, Vijay, Joshi, Amit, Chougule, Anuradha, Bhattacharjee, Atanu, Kumar, Rajiv, More, Sucheta, Goud, Supriya, Karpe, Ashay, Ramaswamy, Anant, Pande, Nikhil, Chandrasekharan, Arun, Goel, Alok, Talreja, Vikas, Mahajan, Abhishek, Janu, Amit, Purandare, Nilendu, Prabhash, Kumar
Publicado no Ecancermedicalscience (2017)

Efficacy of gefitinib in epidermal growth factor receptor-activating mutation-positive nonsmall cell lung cancer: Does exon 19 deletion differ from exon 21 mutation?

Por Joshi, Amit, Patil, Vijay, Noronha, Vanita, Chougule, Anuradha, Bhattacharjee, Atanu, Kumar, Rajiv, Goud, Supriya, More, Sucheta, Ramaswamy, Anant, Karpe, Ashay, Pande, Nikhil, Chandrasekharan, Arun, Goel, Alok, Talreja, Vikas, Mahajan, Abhishek, Janu, Amit, Purandare, Nilendu, Prabhash, Kumar
Publicado no Lung India (2018)

Efficacy of Second-Line Pemetrexed-Carboplatin in EGFR-Activating Mutation-Positive NSCLC: Does Exon 19 Deletion Differ from Exon 21 Mutation?

Por Joshi, Amit, Noronha, Vanita, Patil, Vijay M., Chougule, Anuradha, Bhattacharjee, Atanu, Kumar, Rajiv, Goud, Supriya, More, Sucheta, Ramaswamy, Anant, Karpe, Ashay, Pande, Nikhil, Chandrasekharan, Arun, Goel, Alok, Talreja, Vikas, Mahajan, Abhishek, Janu, Amit, Purandare, Nilendu, Prabhash, Kumar
Publicado no Chemother Res Pract (2017)

Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma

Por Patil, Vijay Maruti, Noronha, Vanita, Joshi, Amit, Choughule, Anuradha Bharat, Bhattacharjee, Atanu, Kumar, Rajiv, Goud, Supriya, More, Sucheta, Ramaswamy, Anant, Karpe, Ashay, Pande, Nikhil, Chandrasekharan, Arun, Goel, Alok, Talreja, Vikas, Mahajan, Abhishek, Janu, Amit, Purandare, Nilendu, Prabhash, Kumar
Publicado no ESMO Open (2017)

Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer

Por Noronha, Vanita, Patil, Vijay Maruti, Joshi, Amit, Mahimkar, Manoj, Patel, Usha, Pandey, Manish Kumar, Chandrasekharan, Arun, Dsouza, Hollis, Bhattacharjee, Atanu, Mahajan, Abhishek, Sabale, Nilesh, Agarwal, Jai Prakash, Ghosh-Laskar, Sarbani, Budrukkar, Ashwini, D’Cruz, Anil K., Chaturvedi, Pankaj, Pai, Prathamesh S., Chaukar, Devendra, Nair, Sudhir, Thiagarajan, Shivakumar, Banavali, Shripad, Prabhash, Kumar
Publicado no Oncotarget (2020)